Bayer Nixes Generic's Anticoagulant Patent
Bayer has persuaded European appellate officials to ditch a Slovenian drugmaker's patent over a compound that helps prevent blood clots, after showing that it lacked key information scientists needed to make...To view the full article, register now.
Already a subscriber? Click here to view full article